These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
240 related articles for article (PubMed ID: 8951184)
1. The new generation of antiepileptic drugs: advantages and disadvantages. Perucca E Br J Clin Pharmacol; 1996 Nov; 42(5):531-43. PubMed ID: 8951184 [TBL] [Abstract][Full Text] [Related]
2. The new antiepileptic drugs: pharmacological and clinical aspects. Gatti G; Bonomi I; Jannuzzi G; Perucca E Curr Pharm Des; 2000 May; 6(8):839-60. PubMed ID: 10828310 [TBL] [Abstract][Full Text] [Related]
3. Clinical pharmacology and therapeutic use of the new antiepileptic drugs. Perucca E Fundam Clin Pharmacol; 2001 Dec; 15(6):405-17. PubMed ID: 11860529 [TBL] [Abstract][Full Text] [Related]
4. Use of antiepileptic drugs in the treatment of epilepsy in people with intellectual disability. Alvarez N; Besag F; Iivanainen M J Intellect Disabil Res; 1998 Dec; 42 Suppl 1():1-15. PubMed ID: 10030426 [TBL] [Abstract][Full Text] [Related]
5. The spectrum of the new antiepileptic drugs. Perucca E Acta Neurol Belg; 1999 Dec; 99(4):231-8. PubMed ID: 10674140 [TBL] [Abstract][Full Text] [Related]
6. Newer antiepileptic drugs. Towards an improved risk-benefit ratio. Patsalos PN; Sander JW Drug Saf; 1994 Jul; 11(1):37-67. PubMed ID: 7917080 [TBL] [Abstract][Full Text] [Related]
7. [Antiepileptic drugs in North America]. Akiyama T; Otsubo H Brain Nerve; 2010 May; 62(5):519-26. PubMed ID: 20450099 [TBL] [Abstract][Full Text] [Related]
8. Drug interactions involving the new second- and third-generation antiepileptic drugs. Johannessen Landmark C; Patsalos PN Expert Rev Neurother; 2010 Jan; 10(1):119-40. PubMed ID: 20021326 [TBL] [Abstract][Full Text] [Related]
9. [Newer antiepileptic drugs]. Matsuura M No To Shinkei; 2007 Feb; 59(2):147-56. PubMed ID: 17315756 [TBL] [Abstract][Full Text] [Related]
10. New antiepileptic drugs: a systematic review of their efficacy and tolerability. Marson AG; Kadir ZA; Chadwick DW BMJ; 1996 Nov; 313(7066):1169-74. PubMed ID: 8916746 [TBL] [Abstract][Full Text] [Related]
11. New antiepileptic drugs: review on drug interactions. Hachad H; Ragueneau-Majlessi I; Levy RH Ther Drug Monit; 2002 Feb; 24(1):91-103. PubMed ID: 11805729 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic variability of newer antiepileptic drugs: when is monitoring needed? Johannessen SI; Tomson T Clin Pharmacokinet; 2006; 45(11):1061-75. PubMed ID: 17048972 [TBL] [Abstract][Full Text] [Related]
13. Enzyme induction and inhibition by new antiepileptic drugs: a review of human studies. Benedetti MS Fundam Clin Pharmacol; 2000; 14(4):301-19. PubMed ID: 11030437 [TBL] [Abstract][Full Text] [Related]
15. [Therapeutic options provided by new antiepileptic drugs]. Baulac M; Arzimanoglou A; Semah F; Cavalcanti D Rev Neurol (Paris); 1997 Feb; 153(1):21-33. PubMed ID: 9296153 [TBL] [Abstract][Full Text] [Related]
16. Treatment of partial seizures in childhood : an overview. Coppola G CNS Drugs; 2004; 18(3):133-56. PubMed ID: 14871158 [TBL] [Abstract][Full Text] [Related]
17. Newer anticonvulsant drugs: role of pharmacology, drug interactions and adverse reactions in drug choice. Natsch S; Hekster YA; Keyser A; Deckers CL; Meinardi H; Renier WO Drug Saf; 1997 Oct; 17(4):228-40. PubMed ID: 9352959 [TBL] [Abstract][Full Text] [Related]
18. Some common issues in the use of antiepileptic drugs. Asconapé JJ Semin Neurol; 2002 Mar; 22(1):27-39. PubMed ID: 12170391 [TBL] [Abstract][Full Text] [Related]